# Adalimumab for Inflammatory Osteoarthritis

> **NCT00686439** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Alberta** · enrollment: 20 (actual)

## Conditions studied

- Osteoarthritis

## Interventions

- **DRUG:** adalimumab
- **DRUG:** adalimumab

## Key facts

- **NCT ID:** NCT00686439
- **Lead sponsor:** University of Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2010-11
- **Final completion:** 2010-11
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2012-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00686439

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00686439, "Adalimumab for Inflammatory Osteoarthritis". Retrieved via AI Analytics 2026-09-28 from https://api.ai-analytics.org/clinical/NCT00686439. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*